Psycho-Social and Psychopathological Features as Predictors of Response to Long Term and High Dosages Methadone Treatment

  • I. Maremmani
  • O. Zolesi
  • P. Castrogiovanni
Conference paper


Pharmacological treatment of heroin addiction with opiate agonists, if carried out according to a correct methodology, produces the most consistent results nowadays. Though United States government authorities and the Italian Health Ministry (Circular 87, 1984) advise it, in the public services it is very difficult to carry out this kind of intervention, because some regional governments, by means of special laws, prevent the realization of long term and “so-called” high dosage treatments.


Drug Addiction Social Adjustment Methadone Maintenance High Dosage Treatment Paranoid Ideation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Castrogiovanni P., Andreani M.F., Maremmani I., Nannini-Innocenti M.A. (1982): Per una valutazione dell’aggressività nell’uomo: contributo alla validazione di un questionario per la tipizzazione del comportamento aggressivo. Rivista di Psichiatria, 17, 276–295Google Scholar
  2. Derogatis L.R., Lipman R.S., Rickels K., (1973): The Hopkins Symptoms Checklist (HSCL): A measure of Primary Symptom Dimensions. In P. Pichot (Ed) “Modern Problems in Pharmacopsychiatry. Karger, Basle, 189–204Google Scholar
  3. Dole V.P., Nyswander M.E. (1965): A medical treatment for diacetylmorphine (heroin) addiction. J.A.M.A. 193: 646–650PubMedCrossRefGoogle Scholar
  4. Dole V.P., Nyswander M.E. (1966): Heroin Addiction: a metabolic disease. Arch. Intern. Med. 120: 19–24.CrossRefGoogle Scholar
  5. Dole V.P., Nyswander M.E., Warner A. (1968): Successful treatment of 750 criminal addicts. J.A.M.A. 206: 2708–2712.PubMedCrossRefGoogle Scholar
  6. Hargreaves W.A. (1983): Methadone dose and duration for maintenance. In J.R. Cooper (Ed) “Research on the treatment of narcotic addiction. State of the art. N.I.D.A. Rockville, Maryland, 19–82Google Scholar
  7. Kreek M.J. (1983): Health consequences associated with the use of Methadone. In: J.R. Cooper (Ed) “Research on the treatment of narcotic addiction. State of the art. N.I.D.A. Rockville, Maryland, 456–491Google Scholar
  8. Nencini R, Belcecchi M.V (1956). Guida alla forma per adulti del P.F.S. di Rosenzweig O.S. FirenzeGoogle Scholar
  9. Schooler N.R., Hogarty G.E., Weissman M.M. (1979): Social Adjustment Scale II.In “Resource material for community mental health program evaluation” (Hargreaves W.A. et al. Editors), A.D.M. 79, 328, 291 ( Printing Authors, Washington, D.C.,)Google Scholar
  10. Smith T.A., Kronick R.F. (1979): The policy culture of drug: ritalin, methadone, and the control of deviant behaviour. Int. J. Addict 12: 993–946Google Scholar
  11. Treece C., Nicholson B (1980).: DSM III personality type and dose levels in methadone maintenance patients. J. Nerv. Men. Dis. 168: 621–628CrossRefGoogle Scholar
  12. Walton R.G., Thornton T.L., Wahl G.F. (1978): Serum methadone as an aid in managing methadone maintenance patients. Int J. Addicts 13: 689–694Google Scholar
  13. Weppner R.S. (1979): Conflicting world views and the delivery of treatment to narcotics addicts: some socio-cultural observations. Soc. SCI. Med. 13: 257–262Google Scholar

Copyright information

© Springer-Verlag/Wien 1991

Authors and Affiliations

  • I. Maremmani
    • 1
    • 2
  • O. Zolesi
    • 1
  • P. Castrogiovanni
    • 1
  1. 1.Psychiatric InstituteUniversity of PisaItaly
  2. 2.Social Diseases Study and Intervention AssociationItaly

Personalised recommendations